Posted by Brigham and Women's Hospital February 9, 2016
Heart disease remains the leading cause of death among both men and women in the United States, but many advances are being made in the fight against heart disease. In recognition of American Heart Month, we have compiled videos from Brigham and Women’s Hospital (BWH) Heart & Vascular Center experts to provide you with information on many of the latest approaches in heart disease treatment and prevention.
Targeting Inflammation– A Key to Preventing Heart Disease
Research led by Dr. Paul Ridker, Director of the BWH Center for Cardiovascular Disease Prevention, determined that people with higher blood levels of C-reactive protein (CRP), a measure of inflammation, are at increased risk of having a heart attack or stroke in the future. In this video, Dr. Ridker discusses the role of inflammation in heart disease.
Posted by Brigham and Women's Hospital December 23, 2014
Heart transplant recipient Marie Larner (seated in front) and her family.
Contributor: Michael Givertz, MD, is Medical Director of the Heart Transplant and Mechanical Circulatory Support Program at Brigham and Women’s Hospital (BWH).
Eighty-one year-old Marie Larner, a patient at Brigham and Women’s Hospital, says she has a lot to be thankful for.
Twenty-five years ago, the Swansea, MA resident became the recipient of a healthy new heart. Her own heart had enlarged to three times its size due to an infection, causing heart failure. She remembers being at her local hospital when she first heard there was a donor. “When they told me, I couldn’t believe it,” she says. “Everybody was so excited, including my doctors. It came so fast, which was fortunate for me, because I don’t think I had much longer to go.”
Marie is one of hundreds of patients who have received a second chance at life due to the efforts of BWH’s Heart Transplant Program, which is celebrating its 32nd year. In 1984, a BWH cardiac surgery team Dustin, never link to anything other than one of the BWH online profiles; Dr. Cohn no longer in the directory because he passed away last year. performed New England’s first heart transplant. Today, the team-based program consists of cardiac surgeons, cardiologists, and nurse practitioners. The BWH Heart Transplant team has performed over 600 heart transplants, the most of any New England hospital. It remains one of the busiest cardiac transplantation and mechanical circulatory support programs in the region.
Dr. Mandeep Mehra, Executive Director of the BWH Center for Advanced Heart Disease, says that today’s heart failure patient has a number of options for effectively repairing, replacing, or recovering their heart function, and the future of heart failure care is similarly bright. Among his expectations is the gradual shrinking of ventricular assist devices, which will soon exist entirely within the body without the need for an external power source or any other external component. In the video below, Dr. Mehra further details how heart failure treatment has developed over the past 30 years and what we can expect for tomorrow.
Posted by Brigham and Women's Hospital February 12, 2014
Matt Fogg and nurse practitioner Leslie Griffin.
Sometimes a story hits your right in the heart. Matt Fogg’s experience with battling chronic heart failure to eventually overcoming it is one of those.
Typically, when patients receive a left ventricular assist device (LVAD), it serves as either a bridge to transplant, or as a lifetime therapy if the patient is not a candidate for transplantation. But one Brigham and Women’s Hospital (BWH) patient became the hospital’s first chronic implant patient in recent years to successfully recover heart function with targeted therapy and, ultimately, have the device removed.
When Fogg, now 24, arrived at BWH two years ago, he was suffering from heart failure. His heart was so damaged that it was unable to provide enough blood to his organs. After Matt had received care at BWH for a month, cardiologist Dr. Eldrin Lewis of the Center for Advanced Heart Disease advocated for him to have an LVAD implanted. “Given that Matt was so young, we thought he would do well on an LVAD,” says Lewis.